Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms
- Autores
- Scarcella, Silvana Andrea; Solana, Hugo Daniel; Larsen, Matías José; Felipe, Antonio Eduardo; Alzola, Ricardo; Lanusse, Carlos Edmundo
- Año de publicación
- 2008
- Idioma
- inglés
- Tipo de recurso
- documento de conferencia
- Estado
- versión publicada
- Descripción
- Fasciolasis, is an emergent zoonotic disease. The drug of choice for its treatment is triclabendazole (TCBZ). Today, the extensive use of TCBZ has already generated resistance. The mechanisms of anthelmintic resistance include involvement of detoxification processes generated through the FMO enzymatic pathway or through drug extrusion pumps such as the P Glycoprotein (P Gp). The aim of the present work was to immune-locate the presence and distribution of P-Gp and FMO in TCBZ susceptible and resistant Fasciola hepatica. The immunohistochemical study confirmed the presence of P Gp in both strains, distributed in the enterocytes and a smaller quantity in the vitellogenic cells and specula. FMO location seems to be restricted to the vitellogenic cells. This distribution pattern was similar for both strains, without differences in their distribution and expression. It is inferred that the resistance may involve modifications at metabolic levels, without detectable morphologic changes, at least not observable by optical microscopy.
Fil: Scarcella, Silvana Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina
Fil: Solana, Hugo Daniel. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina
Fil: Larsen, Matías José. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina
Fil: Felipe, Antonio Eduardo. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina
Fil: Alzola, Ricardo. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina
Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; Argentina
XL Reunión Anual de la Sociedad Argentina de Farmacología Experimental
Tandil
Argentina
Sociedad Argentina de Farmacologia Experimental
Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias - Materia
-
Inmunolocalization
Fasciola
Detoxifying - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/269167
Ver los metadatos del registro completo
id |
CONICETDig_166fe8873fe8f5e2efd572a95ebb9e5e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/269167 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanismsScarcella, Silvana AndreaSolana, Hugo DanielLarsen, Matías JoséFelipe, Antonio EduardoAlzola, RicardoLanusse, Carlos EdmundoInmunolocalizationFasciolaDetoxifyinghttps://purl.org/becyt/ford/4.3https://purl.org/becyt/ford/4Fasciolasis, is an emergent zoonotic disease. The drug of choice for its treatment is triclabendazole (TCBZ). Today, the extensive use of TCBZ has already generated resistance. The mechanisms of anthelmintic resistance include involvement of detoxification processes generated through the FMO enzymatic pathway or through drug extrusion pumps such as the P Glycoprotein (P Gp). The aim of the present work was to immune-locate the presence and distribution of P-Gp and FMO in TCBZ susceptible and resistant Fasciola hepatica. The immunohistochemical study confirmed the presence of P Gp in both strains, distributed in the enterocytes and a smaller quantity in the vitellogenic cells and specula. FMO location seems to be restricted to the vitellogenic cells. This distribution pattern was similar for both strains, without differences in their distribution and expression. It is inferred that the resistance may involve modifications at metabolic levels, without detectable morphologic changes, at least not observable by optical microscopy.Fil: Scarcella, Silvana Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; ArgentinaFil: Solana, Hugo Daniel. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; ArgentinaFil: Larsen, Matías José. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; ArgentinaFil: Felipe, Antonio Eduardo. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; ArgentinaFil: Alzola, Ricardo. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; ArgentinaFil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; ArgentinaXL Reunión Anual de la Sociedad Argentina de Farmacología ExperimentalTandilArgentinaSociedad Argentina de Farmacologia ExperimentalUniversidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias VeterinariasSociedad Argentina de Farmacologia Experimental2008info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/conferenceObjectReuniónBookhttp://purl.org/coar/resource_type/c_5794info:ar-repo/semantics/documentoDeConferenciaapplication/pdfapplication/mswordapplication/pdfhttp://hdl.handle.net/11336/269167Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms; XL Reunión Anual de la Sociedad Argentina de Farmacología Experimental; Tandil; Argentina; 2008; 20-20CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://aafeargentina.org/congresos-aafe/info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:42:20Zoai:ri.conicet.gov.ar:11336/269167instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:42:20.358CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
title |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
spellingShingle |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms Scarcella, Silvana Andrea Inmunolocalization Fasciola Detoxifying |
title_short |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
title_full |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
title_fullStr |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
title_full_unstemmed |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
title_sort |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms |
dc.creator.none.fl_str_mv |
Scarcella, Silvana Andrea Solana, Hugo Daniel Larsen, Matías José Felipe, Antonio Eduardo Alzola, Ricardo Lanusse, Carlos Edmundo |
author |
Scarcella, Silvana Andrea |
author_facet |
Scarcella, Silvana Andrea Solana, Hugo Daniel Larsen, Matías José Felipe, Antonio Eduardo Alzola, Ricardo Lanusse, Carlos Edmundo |
author_role |
author |
author2 |
Solana, Hugo Daniel Larsen, Matías José Felipe, Antonio Eduardo Alzola, Ricardo Lanusse, Carlos Edmundo |
author2_role |
author author author author author |
dc.subject.none.fl_str_mv |
Inmunolocalization Fasciola Detoxifying |
topic |
Inmunolocalization Fasciola Detoxifying |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/4.3 https://purl.org/becyt/ford/4 |
dc.description.none.fl_txt_mv |
Fasciolasis, is an emergent zoonotic disease. The drug of choice for its treatment is triclabendazole (TCBZ). Today, the extensive use of TCBZ has already generated resistance. The mechanisms of anthelmintic resistance include involvement of detoxification processes generated through the FMO enzymatic pathway or through drug extrusion pumps such as the P Glycoprotein (P Gp). The aim of the present work was to immune-locate the presence and distribution of P-Gp and FMO in TCBZ susceptible and resistant Fasciola hepatica. The immunohistochemical study confirmed the presence of P Gp in both strains, distributed in the enterocytes and a smaller quantity in the vitellogenic cells and specula. FMO location seems to be restricted to the vitellogenic cells. This distribution pattern was similar for both strains, without differences in their distribution and expression. It is inferred that the resistance may involve modifications at metabolic levels, without detectable morphologic changes, at least not observable by optical microscopy. Fil: Scarcella, Silvana Andrea. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina Fil: Solana, Hugo Daniel. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina Fil: Larsen, Matías José. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina Fil: Felipe, Antonio Eduardo. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina Fil: Alzola, Ricardo. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Ciencias Biológicas; Argentina Fil: Lanusse, Carlos Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias. Departamento de Fisiopatología. Laboratorio de Farmacología; Argentina XL Reunión Anual de la Sociedad Argentina de Farmacología Experimental Tandil Argentina Sociedad Argentina de Farmacologia Experimental Universidad Nacional del Centro de la Provincia de Buenos Aires. Facultad de Ciencias Veterinarias |
description |
Fasciolasis, is an emergent zoonotic disease. The drug of choice for its treatment is triclabendazole (TCBZ). Today, the extensive use of TCBZ has already generated resistance. The mechanisms of anthelmintic resistance include involvement of detoxification processes generated through the FMO enzymatic pathway or through drug extrusion pumps such as the P Glycoprotein (P Gp). The aim of the present work was to immune-locate the presence and distribution of P-Gp and FMO in TCBZ susceptible and resistant Fasciola hepatica. The immunohistochemical study confirmed the presence of P Gp in both strains, distributed in the enterocytes and a smaller quantity in the vitellogenic cells and specula. FMO location seems to be restricted to the vitellogenic cells. This distribution pattern was similar for both strains, without differences in their distribution and expression. It is inferred that the resistance may involve modifications at metabolic levels, without detectable morphologic changes, at least not observable by optical microscopy. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/conferenceObject Reunión Book http://purl.org/coar/resource_type/c_5794 info:ar-repo/semantics/documentoDeConferencia |
status_str |
publishedVersion |
format |
conferenceObject |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/269167 Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms; XL Reunión Anual de la Sociedad Argentina de Farmacología Experimental; Tandil; Argentina; 2008; 20-20 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/269167 |
identifier_str_mv |
Inmunolocalization of certain detoxifying proteins in Fasciola hepatica: relationship with resistance mechanisms; XL Reunión Anual de la Sociedad Argentina de Farmacología Experimental; Tandil; Argentina; 2008; 20-20 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://aafeargentina.org/congresos-aafe/ |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/msword application/pdf |
dc.publisher.none.fl_str_mv |
Sociedad Argentina de Farmacologia Experimental |
publisher.none.fl_str_mv |
Sociedad Argentina de Farmacologia Experimental |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613333956689920 |
score |
13.070432 |